Abstract

In this study, we propose to synthesize NPs using plant extract containing active biomedical components, with the goal of obtaining NPs that inherit the biomedical activities of the plant. Herein, we report the synthesis of manganese dioxide nanoparticles (VBLE-MnO2 NPs) using the leaves extract of Viola betonicifolia, in which the biological active plant’s secondary metabolites function as both reducing and capping agents. The synthesized NPs were successfully characterized with different spectroscopic techniques. The antibacterial, antifungal, and biofilm inhibition properties of the synthesized VBLE-MnO2 NPs were further explored against a variety of bacteria (Gram-positive and Gram-negative) and mycological species. Additionally, their antioxidant ability against linoleic acid peroxidation inhibition, cytobiocompatibility with hMSC cells, and cytotoxicity against MCF-7 cells were investigated compared to leaves extract and chemically synthesized manganese dioxide NPs (CH-MnO2 NPs). The results were demonstrated that the synthesized VBLE-MnO2 NPs presented excellent antibacterial, antifungal, and biofilm inhibition performance against all the tested microbial species compared to plant leaves extract and CH-MnO2 NPs. Moreover, they also exhibited significant antioxidant potential, which was comparable to the external standard (ascorbic acid); however, it was higher than plant leaves extract and CH-MnO2 NPs. Furthermore, the synthesized CH-MnO2 NPs displayed good cytobiocompatibility with hMSC cells compared to CH-MnO2 NPs. The enhanced antioxidant, antibacterial, antifungal, and biofilm inhibition efficacy as compared to CH-MnO2 NPs might be attributed to the synergistic effect of the VBLE-MnO2 NPs’ physical properties and the adsorbed biologically active phytomolecules from the leaves extract of V. betonicifolia on their surface. Thus, our study establishes a novel ecologically acceptable route for nanomaterials’ fabrication with increased and/or extra medicinal functions derived from their herbal origins.

Highlights

  • Antibiotic and antifungal drug resistance in pathogenic bacterial and fungal species have emerged as an alarming threat globally (Khan et al, 2020a)

  • The synthesized VBLE-MnO2 NPs were successfully characterized with different spectroscopic techniques

  • The synthesized VBLE-MnO2 NPs were investigated for different biological activities

Read more

Summary

Introduction

Antibiotic and antifungal drug resistance in pathogenic bacterial and fungal species have emerged as an alarming threat globally (Khan et al, 2020a). A significant reason behind the antimicrobial drugs not working is the formation of biofilms by these microbials (Khan et al, 2021c) These pathogenic microbials in biofilms form can withstand a thousand dosages of conventional antimicrobial medicines (Khan and Lee, 2020b). These pathogenic microbials have evolved resistance to antimicrobial drugs by developing efflux mechanisms, decreasing the cell wall permeation, modifying the drug targeted sites, etc. The current death burden due to infectious disease caused by pathogenic microbials is around 0.7 million deaths annually, as per World Health Organization This can be risen to approximately 10 million annually by 2050 if effective and novel antimicrobial agents are not developed (Khan et al, 2020a; New report calls for urgent action to avert antimicrobial resistance crisis, 2021). Nanotechnology has emerged and come to the forefront to confront antimicrobial resistance issues by developing nanosized materials

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call